Voloridge Investment Management LLC Sells 675,053 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Voloridge Investment Management LLC reduced its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 27.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,760,534 shares of the health services provider's stock after selling 675,053 shares during the quarter. Voloridge Investment Management LLC owned approximately 1.02% of Teladoc Health worth $16,003,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Twinbeech Capital LP increased its stake in shares of Teladoc Health by 63.8% in the fourth quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider's stock valued at $3,479,000 after buying an additional 149,118 shares in the last quarter. Two Sigma Advisers LP lifted its position in shares of Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after purchasing an additional 1,537,094 shares in the last quarter. Two Sigma Investments LP acquired a new position in shares of Teladoc Health during the fourth quarter worth approximately $18,348,000. Point72 Asset Management L.P. increased its holdings in shares of Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Finally, ProShare Advisors LLC increased its holdings in shares of Teladoc Health by 50.7% in the fourth quarter. ProShare Advisors LLC now owns 48,480 shares of the health services provider's stock valued at $441,000 after purchasing an additional 16,312 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Stock Up 2.9%

TDOC traded up $0.21 during trading on Thursday, hitting $7.18. The company had a trading volume of 2,548,777 shares, compared to its average volume of 6,225,705. The company has a market capitalization of $1.26 billion, a PE ratio of -1.24 and a beta of 1.82. Teladoc Health, Inc. has a one year low of $6.35 and a one year high of $15.21. The firm's 50-day moving average price is $7.34 and its 200 day moving average price is $9.24. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. As a group, equities analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

TDOC has been the subject of a number of research reports. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. The Goldman Sachs Group lowered their price target on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Bank of America lowered their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday. Jefferies Financial Group lowered their price target on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Finally, Citigroup lowered their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a report on Friday, April 25th. Twelve investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, Teladoc Health has a consensus rating of "Hold" and an average target price of $9.60.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 11,011 shares of the company's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.58% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.